Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 1b/2a pilot trial of allopregnanolone

Trial Profile

Phase 1b/2a pilot trial of allopregnanolone

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 20 Sep 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Allopregnanolone (Primary)
  • Indications Niemann-Pick diseases
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Sep 2017 New trial record
    • 13 Sep 2017 According to an Alzheimers Drug Discovery Foundation media release, Roberta Diaz Brinton from the University of Arizona, is conducting this trial.
    • 13 Sep 2017 According to an Alzheimers Drug Discovery Foundation media release, data were presented at the 18th Annual Conference on Alzheimer's Drug Discovery.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top